| fruiting gliding bacteria| Myxobacteria| Myxococcales| Myxococcales Tchan et al. 1948| The Myxobacteria
Environmental Bacteria: Myxobacteria are primarily found in soil environments. They are known for their ability to move as groups, forming swarms, and exhibiting predatory behavior toward other microorganisms. Myxobacteria play roles in the decomposition of organic matter in soil ecosystems.
Secondary Metabolites: Some myxobacteria are known to produce secondary metabolites, including antimicrobial compounds. These compounds may have applications in medicine or biotechnology. However, the direct impact on human health is more related to the potential discovery and development of bioactive compounds rather than pathogenic effects.
Biotechnological Applications: Myxobacteria are of interest in biotechnological research due to their ability to produce bioactive compounds with potential pharmaceutical and agricultural applications. Researchers are exploring the biotechnological potential of myxobacteria for the production of antibiotics and other useful molecules.
Limited Pathogenicity to Humans: Myxobacteria are generally considered non-pathogenic to humans. They do not typically cause diseases in humans, and the focus of research on myxobacteria is often related to their ecological roles and biotechnological potential rather than health impacts.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 0.71 | 6 | 2270 | 0 | 1568 | 338 | 40 | 627.8 | 6 | 2270 | 0 %ile | 100 %ile | ||
biomesight | 17.52 | 0 | 10 | 10 | 170 | 0 | 1040 | 170.1 | 30 | 443.7 | 10 | 150 | 0 %ile | 92 %ile |
thorne | 100 | 18 | 271 | 0 | 251 | 107.9 | 81 | 72.8 | 21 | 231 | 0 %ile | 100 %ile | ||
thryve | 54.15 | 0 | 68 | 22 | 245 | 0 | 581 | 149.3 | 92 | 220.4 | 0 | 295 | 8 %ile | 90.7 %ile |
ubiome | 0.25 | 17 | 30 | 5 | 42 | 23.5 | 24 | 9.2 | 17 | 30 | 25 %ile | 50 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
Thorne (20/80%ile) | 49.74 | 157.48 | 0.005 | 0.0157 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSight | 18.82 % | 0.018 % | 0.051 % | 558.0 | 2965 |
BiomeSightRdp | 12.903 % | 0.008 % | 0.004 % | 4.0 | 31 |
bugspeak | 100 % | 0.005 % | % | 1.0 | 1 |
CerbaLab | 66.667 % | 0.005 % | 0.002 % | 2.0 | 3 |
CosmosId | 3.125 % | 0.003 % | % | 1.0 | 32 |
custom | 1.639 % | 0.002 % | % | 1.0 | 61 |
es-xenogene | 13.793 % | 0.069 % | 0.048 % | 4.0 | 29 |
Medivere | 42.857 % | 0.001 % | 0.001 % | 3.0 | 7 |
SequentiaBiotech | 5.556 % | 0.119 % | 0.152 % | 2.0 | 36 |
Thorne | 85.577 % | 0.006 % | 0.006 % | 89.0 | 104 |
Thryve | 49.353 % | 0.015 % | 0.021 % | 686.0 | 1390 |
Tiny | 50 % | 0.001 % | % | 1.0 | 2 |
uBiome | 0.253 % | 0.002 % | 0.001 % | 2.0 | 792 |
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.